Total R&D Management: Strategies and Tactics for 21st Century Healthcare Manufacturers

Total R&D Management: Strategies and Tactics for 21st Century Healthcare Manufacturers

Total R&D Management: Strategies and Tactics for 21st Century Healthcare Manufacturers

Total R&D Management: Strategies and Tactics for 21st Century Healthcare Manufacturers

Synopsis

Drawing on a lifetime of experience, Roger Dobbah gives readers an in-depth view of R&D survival strategies and tactics and demonstrates how to apply them to any organization. The author provides insights into the role of R&D, the crucial topic of creativity and innovation, and the differences and similarities between general management and R&D management. He covers R&D resources, organizational structures, internal and external environments, R&D interface with other functions, objectives and adaptation, and integration of strategies. It includes coverage of the new R&D dimension of pharmacoeconomics and a full discussion of the regulatory environment impacting the present and future of R&D.

Excerpt

The healthcare industry is a rather recent development in the industrial world. However, elements of research and development (R&D) in that area used for the treatment of diseases have been flourishing since almost the dawn of ages. the shaman and the medicine man or woman of yesteryear used the strategies of observation and trial and error in their practice of the art of healing with variable results. Folk medicine, which was the result of R&D at its most primitive level, seems, paradoxically in the 1990s, to be exhibiting a resurgence under the name of alternative medicine. in a time when gene and cell therapies appear to be the next frontier, a return to the roots-no pun intended-is a reflection on human nature. Outcomes of therapies are now a part of the picture of healthcare under the guise of pharmacoeconomics; however, in time past, the outcome of therapy, especially when applied to the power structure of the era-ranging from head cave person to kings or queens-was crucial to the medicine person. Often, if the therapy was not successful, the outcome for the healer was death. This motivated the healer to try remedies on the less fortunate, which, as the legend would state, was the beginning of R&D. in the present, malpractice insurance has taken a more genteel, if not more expensive, approach to unexpected outcomes.

There is no doubt that some of the remedies prescribed by the early medicine person were placebic rather than curative. This gave rise later to a new branch of R&D in the arena of psychosomatic treatments. the early R&D practitioners, not knowing about anatomy or physiology and having no clue to the origin and cause of disease, were able through careful observations and through trial and error to develop a body of knowledge that was considerable, relevant, and operational.

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.